Tag: ASN 2020

Novartis’ rare renal disease candidate shows promise in phase II

by Lucy Parsons | Oct 27, 2020 | News | 0

Investigational oral treatment is being investigated in C3 glomerulopathy

Read More

AZ presents new real-world chronic kidney disease data at ASN 2020

by Lucy Parsons | Oct 26, 2020 | News | 0

Initial key findings from the DISCOVER-Chronic Kidney Disease study revealed

Read More

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999